Overview of psychiatric disorders and the role of newer antidepressants.
Charney
Dennis S
DS
Mood and Anxiety Disorders Research Program, National Institute of Mental Health, Bethesda, MD 20892, USA. charney@nih.gov
Grothe
Dale R
DR
Smith
Sherry L
SL
Brady
Kathleen T
KT
Kaltsounis-Puckett
Juliana
J
Wright
Clinton W
CW
Laird
Lyle K
LK
Rush
A John
AJ
D000928:Antidepressive Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010879:Piperazines; D012893:Sleep Wake Disorders / Q000188:drug therapy; D014230:Triazoles / Q000627:therapeutic use
D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D010879:Piperazines; D014230:Triazoles; C051752:nefazodone